Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP727507.RADuMITyQhapgrjJ5LemZBHaCXHHu5MfTaLb1iqMpSjUM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP727507.RADuMITyQhapgrjJ5LemZBHaCXHHu5MfTaLb1iqMpSjUM130_assertion type Assertion NP727507.RADuMITyQhapgrjJ5LemZBHaCXHHu5MfTaLb1iqMpSjUM130_head.
- NP727507.RADuMITyQhapgrjJ5LemZBHaCXHHu5MfTaLb1iqMpSjUM130_assertion description "[We have measured the gene dosage of the epidermal growth factor receptor (EGFR), mouse double minute 2 (MDM2), and cyclin-dependent kinase 4 (CDK4) genes in a series of brain tumor specimens and correlated their amplification status with standard prognostic factors and survival.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP727507.RADuMITyQhapgrjJ5LemZBHaCXHHu5MfTaLb1iqMpSjUM130_provenance.
- NP727507.RADuMITyQhapgrjJ5LemZBHaCXHHu5MfTaLb1iqMpSjUM130_assertion evidence source_evidence_literature NP727507.RADuMITyQhapgrjJ5LemZBHaCXHHu5MfTaLb1iqMpSjUM130_provenance.
- NP727507.RADuMITyQhapgrjJ5LemZBHaCXHHu5MfTaLb1iqMpSjUM130_assertion SIO_000772 9516974 NP727507.RADuMITyQhapgrjJ5LemZBHaCXHHu5MfTaLb1iqMpSjUM130_provenance.
- NP727507.RADuMITyQhapgrjJ5LemZBHaCXHHu5MfTaLb1iqMpSjUM130_assertion wasDerivedFrom befree-20140225 NP727507.RADuMITyQhapgrjJ5LemZBHaCXHHu5MfTaLb1iqMpSjUM130_provenance.
- NP727507.RADuMITyQhapgrjJ5LemZBHaCXHHu5MfTaLb1iqMpSjUM130_assertion wasGeneratedBy ECO_0000203 NP727507.RADuMITyQhapgrjJ5LemZBHaCXHHu5MfTaLb1iqMpSjUM130_provenance.